You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
維亞生物(01873.HK)建議發行2.8億美元有擔保可轉換債券
格隆匯 12-18 07:07

格隆匯 12 月 18日丨維亞生物(01873.HK)發佈公告,2020年12月17日,公司全資附屬公司Viva Biotech(作為發行人)、公司(作為擔保人)及經辦人訂立認購協議,據此並在達成所載若干條件的前提下,發行人已同意發行2.8億美元1.00%於2025年到期的有擔保可轉換債券,且經辦人已同意認購及支付或促使認購人認購及支付由公司擔保的本金額2.8億美元的債券。

假設按初步轉換價每股股份11.6370港元悉數轉換債券,債券將可轉換為186,519,893股轉換股份,相當於公司於該公告日期的已發行股本總數約9.75%,以及公司於該公告日期因悉數轉換債券而擴大的已發行股本總數約8.88%。在條件及條款所載情況下,債券可轉換為轉換股份。初步轉換價為每股轉換股份11.6370港元,其較12月17日(即簽署認購協議的交易日)收市價每股股份8.62港元溢價35.0%。

轉換股份將予悉數繳足並於所有方面與相關登記日期當時已發行股份享有同等權利。認購債券的所得款項總額將為2.8億美元。有關發行債券的國家發改委企業借用外債備案登記證明經已獲取。公司將向香港聯交所申請批准債券及因轉換債券而配發及發行的轉換股份上市及買賣。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account